Re-analysis of Clinical Features of 89 Patients with Autoimmune Hepatitis Using the Revised Scoring System Proposed by the International Autoimmune Hepatitis Group
Objective The diagnostic criteria of autoimmune hepatitis (AIH) were recently modified by the International Autoimmune Hepatitis Group. This study was performed to assess the impact of the revised scoring system on the diagnosis of AIH. Patients and Methods We re-analyzed the clinical features of 89...
Saved in:
Published in | Internal Medicine Vol. 39; no. 12; pp. 1008 - 1012 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Tokyo
The Japanese Society of Internal Medicine
01.12.2000
Japanese Society of Internal Medicine |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objective The diagnostic criteria of autoimmune hepatitis (AIH) were recently modified by the International Autoimmune Hepatitis Group. This study was performed to assess the impact of the revised scoring system on the diagnosis of AIH. Patients and Methods We re-analyzed the clinical features of 89 patients diagnosed as AIH in Nagasaki Prefecture, Japan, using the revised scoring system, and compared the scores and final diagnosis with our previously published results using the original system. Results Of the 89 patients with AIH, 40 (45%) were classified using the new system as "definite" AIH, 41 (46%) as "probable" AIH, and 8 (9%) patients were categorized as "others". Of these, 37 (42%), 35 (39%), and 4 (4%) patients who were classified as "definite", "probable", and "others" by the original system remained in the same category by the revised system, respectively. However, 3, 4, and 6 patients were re-categorized as "definite" from "probable", "others" from "probable", and "probable" from "definite", respectively. The difference in aggregate scores between the above two systems ranged from -5 to +2. The main contributing factors to the changes in aggregate AIH score were "other autoimmune disease(s)" and "interface hepatitis without lobular involvement and bridging necrosis on liver histology". However, the main contributing factors to the demotions from "definite" to "probable" and form "probable" to "others" were those related to the characteristics of biliary diseases, i.e., antimitochondrial antibody positive, biliary changes in liver histology, and alkaline phosphatase: aspartate aminotransferase ratio between 1.5 and 3.0. Moreover, two patients who had no histological evidence of AIH were both re-categorized as "others" from "probable" AIH. Conclusion Our results indicated that the diagnosis, whether based on the revised or original system, was the same in the majority of AIH patients, but the revised scoring system excluded cases who had features suggestive of biliary diseases from "definite" AIH, and also confirmed that a diagnosis of "definite" AIH should not be made without liver histology. (Internal Medicine 39: 1008-1012, 2000) |
---|---|
AbstractList | The diagnostic criteria of autoimmune hepatitis (AIH) were recently modified by the International Autoimmune Hepatitis Group. This study was performed to assess the impact of the revised scoring system on the diagnosis of AIH.
We re-analyzed the clinical features of 89 patients diagnosed as AIH in Nagasaki Prefecture, Japan, using the revised scoring system, and compared the scores and final diagnosis with our previously published results using the original system.
Of the 89 patients with AIH, 40 (45%) were classified using the new system as "definite" AIH, 41 (46%) as "probable" AIH, and 8 (9%) patients were categorized as "others". Of these, 37 (42%), 35 (39%), and 4 (4%) patients who were classified as "definite", "probable", and "others" by the original system remained in the same category by the revised system, respectively. However, 3, 4, and 6 patients were re-categorized as "definite" from "probable", "others" from "probable", and "probable" from "definite", respectively. The difference in aggregate scores between the above two systems ranged from -5 to +2. The main contributing factors to the changes in aggregate AIH score were "other autoimmune disease(s)" and "interface hepatitis without lobular involvement and bridging necrosis on liver histology". However, the main contributing factors to the demotions from "definite" to "probable" and form "probable" to "others" were those related to the characteristics of biliary diseases, i.e., antimitochondrial antibody positive, biliary changes in liver histology, and alkaline phosphatase: aspartate aminotransferase ratio between 1.5 and 3.0. Moreover, two patients who had no histological evidence of AIH were both re-categorized as "others" from "probable" AIH.
Our results indicated that the diagnosis, whether based on the revised or original system, was the same in the majority of AIH patients, but the revised scoring system excluded cases who had features suggestive of biliary diseases from "definite" AIH, and also confirmed that a diagnosis of "definite" AIH should not be made without liver histology. Objective The diagnostic criteria of autoimmune hepatitis (AIH) were recently modified by the International Autoimmune Hepatitis Group. This study was performed to assess the impact of the revised scoring system on the diagnosis of AIH. Patients and Methods We re-analyzed the clinical features of 89 patients diagnosed as AIH in Nagasaki Prefecture, Japan, using the revised scoring system, and compared the scores and final diagnosis with our previously published results using the original system. Results Of the 89 patients with AIH, 40 (45%) were classified using the new system as "definite" AIH, 41 (46%) as "probable" AIH, and 8 (9%) patients were categorized as "others". Of these, 37 (42%), 35 (39%), and 4 (4%) patients who were classified as "definite", "probable", and "others" by the original system remained in the same category by the revised system, respectively. However, 3, 4, and 6 patients were re-categorized as "definite" from "probable", "others" from "probable", and "probable" from "definite", respectively. The difference in aggregate scores between the above two systems ranged from -5 to +2. The main contributing factors to the changes in aggregate AIH score were "other autoimmune disease(s)" and "interface hepatitis without lobular involvement and bridging necrosis on liver histology". However, the main contributing factors to the demotions from "definite" to "probable" and form "probable" to "others" were those related to the characteristics of biliary diseases, i.e., antimitochondrial antibody positive, biliary changes in liver histology, and alkaline phosphatase: aspartate aminotransferase ratio between 1.5 and 3.0. Moreover, two patients who had no histological evidence of AIH were both re-categorized as "others" from "probable" AIH. Conclusion Our results indicated that the diagnosis, whether based on the revised or original system, was the same in the majority of AIH patients, but the revised scoring system excluded cases who had features suggestive of biliary diseases from "definite" AIH, and also confirmed that a diagnosis of "definite" AIH should not be made without liver histology. (Internal Medicine 39: 1008-1012, 2000) |
Author | KANEMATSU, Takashi KOGA, Michiaki KOHNO, Shigeru KUSUMOTO, Yukio OMAGARIU, Katsuhisa NAKATA, Keisuke MASUDA, Jun-ichi FURUKAWA, Ryuji KATO, Yuji YANO, Michitami TAJIMA, Heiichiro TANIOKA, Hajime MORI, Iwao |
Author_xml | – sequence: 1 fullname: OMAGARIU, Katsuhisa organization: the Second Department of Internal Medicine, Nagasaki University School of Medicine – sequence: 2 fullname: MASUDA, Jun-ichi organization: the Second Department of Internal Medicine, Nagasaki University School of Medicine – sequence: 3 fullname: KATO, Yuji organization: the First Department of Internal Medicine, Nagasaki University School of Medicine – sequence: 4 fullname: NAKATA, Keisuke organization: the First Department of Internal Medicine, Nagasaki University School of Medicine – sequence: 5 fullname: KANEMATSU, Takashi organization: the Second Department of Surgery, Nagasaki University School of Medicine – sequence: 6 fullname: KUSUMOTO, Yukio organization: Department of Internal Medicine, Nagasaki City Hospital – sequence: 7 fullname: MORI, Iwao organization: Department of Internal Medicine, Nagasaki City Hospital – sequence: 8 fullname: FURUKAWA, Ryuji organization: Department of Internal Medicine, Nagasaki Red Cross Atomic Bomb Hospital – sequence: 9 fullname: TANIOKA, Hajime organization: Department of Internal Medicine, Sasebo Municipal General Hospital – sequence: 10 fullname: TAJIMA, Heiichiro organization: Department of Internal Medicine, Nagasaki Rousai Hospital – sequence: 11 fullname: KOGA, Michiaki organization: Institute for Clinical Research, Nagasaki Chuo National Hospital – sequence: 12 fullname: YANO, Michitami organization: Institute for Clinical Research, Nagasaki Chuo National Hospital – sequence: 13 fullname: KOHNO, Shigeru organization: the Second Department of Internal Medicine, Nagasaki University School of Medicine |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=903755$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/11197782$$D View this record in MEDLINE/PubMed |
BookMark | eNptkN1q3DAQhUVJaTZpX6EIeu2tZa0s6TIszQ8EGrLNtRnL46yCLRtJbtnn6YtW3t1uIO3NCOZ8Z2Z0LsiZGxwSQlm-LFipv1oX0TvoemyssQ6XXC9Znqt3ZMH4Smey4OKMLHLNVFakck4uQnjJc66kLj6Qc8aYllIVC_L7ETNIk3bBBjq0dN1ZZw109BohTh73TaXpA0SLLgb6y8YtvZriYPt-ckhvcUxSTO6nYN0zjVukj_jTBmzoxgx-7m12IWJPH_wwDnO_3u2xu8Mvoh3SAf-feeOHafxI3rfQBfx0fC_J0_W3H-vb7P77zd366j4zQoiYNUZxbTSsyhKUbqCUsjUrpUULRut6xU3RSoOgGlEyUzAmmlLVDLippVBc8UuiDnONH0Lw2Fajtz34XcXyas69ept7xXU1556snw_WcaqT-Go8Bp2AL0cAQoq39eCMDSdO51wKkajNgXoJEZ7xJIOP1nT4z36mdbG_4W-djznRZgu-Qsf_AFpDtHY |
CitedBy_id | crossref_primary_10_1002_hep_22322 crossref_primary_10_1007_s40266_018_0556_0 crossref_primary_10_1097_00001574_200205000_00007 crossref_primary_10_1097_00042737_200406000_00012 crossref_primary_10_3390_diagnostics14020210 crossref_primary_10_1016_j_jhep_2010_06_032 crossref_primary_10_3892_etm_2013_1366 crossref_primary_10_1586_eem_09_6 crossref_primary_10_3390_biology12030479 crossref_primary_10_1053_jhep_2002_34944 crossref_primary_10_33590_emjhepatol_10313935 |
ContentType | Journal Article |
Copyright | The Japanese Society of Internal Medicine 2001 INIST-CNRS |
Copyright_xml | – notice: The Japanese Society of Internal Medicine – notice: 2001 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION |
DOI | 10.2169/internalmedicine.39.1008 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1349-7235 |
EndPage | 1012 |
ExternalDocumentID | 10_2169_internalmedicine_39_1008 11197782 903755 article_internalmedicine1992_39_12_39_12_1008_article_char_en |
Genre | Validation Studies Comparative Study Review Journal Article |
GeographicLocations | Asia Japan |
GeographicLocations_xml | – name: Japan |
GroupedDBID | --- .55 29J 2WC 3O- 53G 5GY 7.U AAPBV AAUGY ACPRK ADBBV ADRAZ AENEX AFRAH ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CS3 DIK DU5 EBS EJD EMOBN F5P HYE JSF JSH M48 M~E OK1 P2P RJT RNS RPM RZJ TKC TR2 X7M XSB IQODW CGR CUY CVF ECM EIF NPM PGMZT AAYXX CITATION |
ID | FETCH-LOGICAL-c555t-dc839c9a466a89da677fc4895fac99b43c2f7cea8d561c2115d68b1a3cb758383 |
ISSN | 0918-2918 |
IngestDate | Fri Aug 23 04:02:21 EDT 2024 Sat Sep 28 08:40:35 EDT 2024 Sun Oct 29 17:06:44 EDT 2023 Thu Aug 17 20:27:40 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | Autoimmunity Human Hepatitis Liver Digestive diseases Hepatic disease Histology Serology Diagnosis |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c555t-dc839c9a466a89da677fc4895fac99b43c2f7cea8d561c2115d68b1a3cb758383 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/internalmedicine1992/39/12/39_12_1008/_article/-char/en |
PMID | 11197782 |
PageCount | 5 |
ParticipantIDs | crossref_primary_10_2169_internalmedicine_39_1008 pubmed_primary_11197782 pascalfrancis_primary_903755 jstage_primary_article_internalmedicine1992_39_12_39_12_1008_article_char_en |
PublicationCentury | 2000 |
PublicationDate | 2000-12-01 |
PublicationDateYYYYMMDD | 2000-12-01 |
PublicationDate_xml | – month: 12 year: 2000 text: 2000-12-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Tokyo |
PublicationPlace_xml | – name: Tokyo – name: Japan |
PublicationTitle | Internal Medicine |
PublicationTitleAlternate | Intern. Med. |
PublicationYear | 2000 |
Publisher | The Japanese Society of Internal Medicine Japanese Society of Internal Medicine |
Publisher_xml | – name: The Japanese Society of Internal Medicine – name: Japanese Society of Internal Medicine |
References | 1) Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 18: 998-1005, 1993. 11) McFarlane IG. The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis. Gut 42:599-602, 1998. 5) Gordon SC. Diagnostic criteria, clinical manifestations and natural history of autoimmune hepatitis, in: Autoimmune Liver Diseases. 2nd ed. Krawitt EL, Wiesner RH, Nishioka M, Eds. Elsevier, Amsterdam, 1998: 343-360. 9) McNair ANB, Moloney M, Portmann BC, Williams R, McFarlane IG. Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases. Am J Gastroenterol 93: 777-784, 1998. 2) Omagari K, Kinoshita H, Kato Y, et al. Clinical features of 89 patients with autoimmune hepatitis in Nagasaki Prefecture, Japan. J Gastroenterol 34: 221-226, 1999. 4) Toda G, Zeniya M, Watanabe F, et al. Present status of autoimmune hepatitis in Japan-Correlating the characteristics with international criteria in an area with a high rate of HCV infection. J Hepatol 26: 1207-1212, 1997. 7) Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med 125:588-598, 1996. 3) International Autoimmune Hepatitis Group Report. Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31: 929-938, 1999. 6) Toda G. Interferon or corticosteroid: Treatment of patients with chronic hepatitis C positive for serum markers of autoimmune diseases. Intern Med 36: 233-235, 1997. 8) Czaja AJ. Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology 28: 360-365, 1998. 10) Mackay IR. Autoimmune disease overlaps and the liver: Two for the price of one? J Gastroenterol Hepatol 15: 3-8, 2000. 12) Mackay IR, Davies JM, Rowley MJ. Towards the pathogenesis of autoimmune liver disease. J Autoimmun 13: 163-169, 1999. 11197810 - Intern Med. 2000 Dec;39(12):999-1000 |
References_xml | |
SSID | ssj0038792 |
Score | 1.6796536 |
SecondaryResourceType | review_article |
Snippet | Objective The diagnostic criteria of autoimmune hepatitis (AIH) were recently modified by the International Autoimmune Hepatitis Group. This study was... The diagnostic criteria of autoimmune hepatitis (AIH) were recently modified by the International Autoimmune Hepatitis Group. This study was performed to... |
SourceID | crossref pubmed pascalfrancis jstage |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1008 |
SubjectTerms | Adult Aged Alanine Transaminase - blood Alcohol Drinking - epidemiology Alkaline Phosphatase - blood Antibodies, Antinuclear - blood Antibody Specificity Aspartate Aminotransferases - blood Autoantibodies - blood Autoantibodies - immunology Autoimmune Diseases - diagnosis Autoimmune Diseases - epidemiology Autoimmune Diseases - genetics Autoimmune Diseases - immunology Autoimmune Diseases - pathology autoimmune hepatitis Bile Ducts - pathology Biological and medical sciences Diagnosis, Differential Female Gastroenterology. Liver. Pancreas. Abdomen Genetic Predisposition to Disease Genotype Hepatitis, Autoimmune - diagnosis Hepatitis, Autoimmune - epidemiology Hepatitis, Autoimmune - genetics Hepatitis, Autoimmune - immunology Hepatitis, Autoimmune - pathology Hepatitis, Viral, Human - diagnosis HLA-DR Antigens - analysis HLA-DR Antigens - genetics Humans Japan - epidemiology Liver Diseases, Alcoholic - diagnosis Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical sciences Middle Aged Mitochondria, Liver - immunology Other diseases. Semiology Retrospective Studies revised international AIH scoring system |
Title | Re-analysis of Clinical Features of 89 Patients with Autoimmune Hepatitis Using the Revised Scoring System Proposed by the International Autoimmune Hepatitis Group |
URI | https://www.jstage.jst.go.jp/article/internalmedicine1992/39/12/39_12_1008/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/11197782 |
Volume | 39 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Internal Medicine, 2000, Vol.39(12), pp.1008-1012 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1ba9swFBZtN8ZgjN2XLRt62Ku7-iJbejTdpd2WFkoCfTOyLFNnkITaftj-zv7ozpEsO0kz2O1FBGGJY74vR0fyd44IecOL2C8Ujzwe5EdeJHLmifCo8FikJfPLWOcSzyEnZ_HJLPp0yS739sdrqqW2yQ_V9515JX-DKvQBrpgl-wfI9pNCB_wGfKEFhKH9LYwvtCfXioocuyxHjOvaa1tOlgssw18NiWxp2ywrzArRsOagnrqB0VY5gEEofiyoMQpVVppnS5pjQsFqWXfhai-4dCeJO-ccjrXmg1zeRL-TrQ_655P0Y3pxOuvkHXV7VdX9cjEBz_8utRkkC69SV1W_SKTTc7OEtPO-7yyF3tRmHFV1-1VvHGtsS0RMYhyEC3gNZy9g7ZJrblranWj6mFDSuXNt_XkYCS8JbEUU5_Bt9SRH7GDNfWOlo7VQAGuf7VpmAj_GKq1VZ4tTQRwCQ4cZNop4dxTJtoeg-DcLRea7Fsdn7mlMvAOe75NbAbhRI0I4_ezijJAn5srv_rWtTg1te_sryzaCr9tz2H9gYYl7K1kDOUt7k8vW_srEWdMH5H63QaKpNe4h2dOLR-SOw-Ex-bFGerosqSM9daTHTi6oIz1F0tOBoLQnKDWkp8Bm2pGedqSnlvTUkZ7m38xjG6TfPach_RMy-_B-enzidTeNeIox1njgrUKhhIziWHJRyDhJShVxwUqphMijUAVlorTkBWw3VAC7qCLmuS9DlSeoOwifkoPFcqGfExqUZRGGEYTOgkUlhMOFDoRiMsw152WQjIjvIMhWtqAMgJ4hbDfYYTgBsI3IF4tVP-Kf-DQi4w3E-1kFXojNRuSZJcBgH2oNYCvx4v_a8ZLcHf75Y3LQXLf6FYT4Tf7aMP0n8mMLMw |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Re-analysis+of+Clinical+Features+of+89+Patients+with+Autoimmune+Hepatitis+Using+the+Revised+Scoring+System+Proposed+by+the+International+Autoimmune+Hepatitis+Group&rft.jtitle=Internal+Medicine&rft.au=OMAGARIU%2C+Katsuhisa&rft.au=MASUDA%2C+Jun-ichi&rft.au=KATO%2C+Yuji&rft.au=NAKATA%2C+Keisuke&rft.date=2000-12-01&rft.pub=The+Japanese+Society+of+Internal+Medicine&rft.issn=0918-2918&rft.eissn=1349-7235&rft.volume=39&rft.issue=12&rft.spage=1008&rft.epage=1012&rft_id=info:doi/10.2169%2Finternalmedicine.39.1008&rft.externalDocID=article_internalmedicine1992_39_12_39_12_1008_article_char_en |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0918-2918&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0918-2918&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0918-2918&client=summon |